跳到正文
OpenAI· @OpenAI · X·· 26 天前AI 评分47
AI 导读

GPT-Rosalind 在 Perry 综合征相关 DCTN1 的小鼠脑数据中提出,胆固醇可能未到达神经元所需位置,为神经退行性疾病提供可检验机制。它与 PerturbAI、Scripps Research 合作,让数千个智能体并行,用 32 分钟关联数百万小鼠脑细胞基因表达结果与文献。该合作正扩展至新药靶点识别。

正文 · 原文

GPT-Rosalind surfaced a new lead for drug discovery: could restoring cholesterol transport protect neurons from degeneration?

DCTN1 is a gene linked to Perry syndrome, a rare neurodegenerative disorder. In mouse-brain data, disrupting it increased expression of genes involved in making cholesterol. GPT-Rosalind suggested a possible explanation: cholesterol may not be reaching where neurons need it.

That gives scientists a specific mechanism to test and, if confirmed, a direction for developing new treatments for neurodegenerative disorders.

With @perturbai_tx and @scrippsresearch, a team of thousands of GPT-Rosalind agents worked in parallel, connecting gene-expression results from millions of mouse brain cells with scientific literature in just 32 minutes. We’re now expanding this collaboration to identify new drug targets.

https://openai.com/index/scaling-ai-research-for-complex-biological-data/

来源:OpenAI · x.com